A. Monaco, R. Neve, C. Colletti-feener, C. Bertelson, D. Kurnit et al., Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene, Nature, vol.28, issue.6089, pp.646-50, 1986.
DOI : 10.1038/323646a0

M. Koenig, E. Hoffman, C. Bertelson, A. Monaco, C. Feener et al., Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals, Cell, vol.50, issue.3, pp.509-526, 1987.
DOI : 10.1016/0092-8674(87)90504-6

A. Monaco, C. Bertelson, S. Liechti-gallati, H. Moser, and L. Kunkel, An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus, Genomics, vol.2, issue.1, pp.90-95, 1988.
DOI : 10.1016/0888-7543(88)90113-9

M. Koenig, A. Beggs, M. Moyer, S. Scherpf, K. Heindrich et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am J Hum Genet, vol.45, pp.498-506, 1989.

A. Goyenvalle and K. Davies, Engineering Exon-Skipping Vectors Expressing U7 snRNA Constructs for Duchenne Muscular Dystrophy Gene Therapy, Methods Mol Biol, vol.709, pp.179-96, 2011.
DOI : 10.1007/978-1-61737-982-6_11

C. Nelson, C. Hakim, D. Ousterout, P. Thakore, E. Moreb et al., In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy, Science, vol.123, issue.72, pp.403-410, 2016.
DOI : 10.1242/jcs.064808

M. Tabebordbar, K. Zhu, J. Cheng, W. Chew, J. Widrick et al., In vivo gene editing in dystrophic mouse muscle and muscle stem cells, vivo gene editing in dystrophic mouse muscle and muscle stem cells, pp.407-418, 2016.
DOI : 10.1038/mtm.2014.38

C. Béroud, S. Tuffery-giraud, M. Matsuo, D. Hamroun, V. Humbertclaude et al., Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy, Human Mutation, vol.18, issue.Web Server issu, pp.196-202, 2007.
DOI : 10.1016/S0002-9440(10)65354-0

C. Young, M. Hicks, N. Ermolova, H. Nakano, J. M. Younesi et al., A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells, Cell Stem Cell, vol.18, issue.4, pp.533-573, 2016.
DOI : 10.1016/j.stem.2016.01.021

J. Ervasti and K. Campbell, A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin, The Journal of Cell Biology, vol.122, issue.4, pp.809-832, 1993.
DOI : 10.1083/jcb.122.4.809

K. Ohlendieck, K. Matsumura, V. Ionasescu, J. Towbin, E. Bosch et al., Duchenne muscular dystrophy: Deficiency of dystrophin-associated proteins in the sarcolemma, Neurology, vol.43, issue.4, pp.795-800, 1993.
DOI : 10.1212/WNL.43.4.795

W. Chang, S. Iannaccone, K. Lau, B. Masters, T. Mccabe et al., Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy., Proceedings of the National Academy of Sciences, vol.93, issue.17, pp.9142-9149, 1996.
DOI : 10.1073/pnas.93.17.9142

J. Stamler and G. Meissner, Physiology of Nitric Oxide in Skeletal Muscle, Physiological Reviews, vol.267, issue.1, pp.209-246, 2001.
DOI : 10.1038/333466a0

D. Cacchiarelli, J. Martone, E. Girardi, M. Cesana, T. Incitti et al., MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway, Cell Metabolism, vol.12, issue.4, pp.341-51, 2010.
DOI : 10.1016/j.cmet.2010.07.008

A. Aguiar, I. Vechetti-júnior, R. Souza, W. Piedade, F. Pacagnelli et al., Nitric oxide synthase inhibition impairs muscle regrowth following immobilization, Nitric Oxide, vol.69, pp.22-29, 2017.
DOI : 10.1016/j.niox.2017.07.006

J. Anderson, A. Zhu, and T. Mizuno, Nitric oxide treatment attenuates muscle atrophy during hind limb suspension in mice, Free Radical Biology and Medicine, vol.115, pp.458-70, 2018.
DOI : 10.1016/j.freeradbiomed.2017.12.021

S. Baldelli, D. Barbato, G. Tatulli, K. Aquilano, and M. Ciriolo, The role of nNOS and PGC-1?? in skeletal muscle cells, Journal of Cell Science, vol.127, issue.22, pp.4813-4833, 2014.
DOI : 10.1242/jcs.154229

J. Brenman, D. Chao, H. Xia, K. Aldape, and D. Bredt, Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy, Cell, vol.82, issue.5, pp.743-52, 1995.
DOI : 10.1016/0092-8674(95)90471-9

D. Chao, J. Gorospe, J. Brenman, J. Rafael, M. Peters et al., Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy, Journal of Experimental Medicine, vol.184, issue.2, pp.609-627, 1996.
DOI : 10.1084/jem.184.2.609

Y. Kobayashi, E. Rader, R. Crawford, N. Iyengar, D. Thedens et al., Sarcolemma-localized nNOS is required to maintain activity after mild exercise, Nature, vol.34, issue.7221, pp.511-516, 2008.
DOI : 10.1038/nature07414

J. Percival, K. Anderson, P. Huang, M. Adams, and S. Froehner, Golgi and sarcolemmal neuronal NOS differentially regulate contraction-induced fatigue and vasoconstriction in exercising mouse skeletal muscle, Journal of Clinical Investigation, vol.120, issue.3, pp.816-842, 2010.
DOI : 10.1172/JCI40736DS1

C. Gentil, F. Leturcq, B. Yaou, R. Kaplan, J. Laforet et al., G.P.75 Variable phenotype of del45???55 Becker patients correlated to nNOS?? mislocalization and RYR1 hypernitrosylation, Neuromuscular Disorders, vol.22, issue.9-10, pp.3449-60, 2012.
DOI : 10.1016/j.nmd.2012.06.109
URL : https://hal.archives-ouvertes.fr/hal-00146222

S. Greco, D. Simone, M. Colussi, C. Zaccagnini, G. Fasanaro et al., Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia, The FASEB Journal, vol.23, issue.10, pp.3335-3381, 2009.
DOI : 10.1016/S0070-2153(08)00609-1

N. Vignier, F. Amor, P. Fogel, A. Duvallet, J. Poupiot et al., Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies, PLoS ONE, vol.31, issue.2, p.55281, 2013.
DOI : 10.1371/journal.pone.0055281.s004

L. Jeanson-leh, J. Lameth, S. Krimi, J. Buisset, F. Amor et al., Serum Profiling Identifies Novel Muscle miRNA and Cardiomyopathy-Related miRNA Biomarkers in Golden Retriever Muscular Dystrophy Dogs and Duchenne Muscular Dystrophy Patients, The American Journal of Pathology, vol.184, issue.11, pp.2885-98, 2014.
DOI : 10.1016/j.ajpath.2014.07.021

J. Hu, M. Kong, Y. Ye, S. Hong, L. Cheng et al., Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy, Journal of Neurochemistry, vol.56, issue.5, pp.877-83, 2014.
DOI : 10.1373/clinchem.2010.147850

D. Bartel, MicroRNAs, Cell, vol.116, issue.2, pp.281-97, 2004.
DOI : 10.1016/S0092-8674(04)00045-5
URL : https://hal.archives-ouvertes.fr/hal-00369966

M. Horak, J. Novak, and J. Bienertova-vasku, Muscle-specific microRNAs in skeletal muscle development, Developmental Biology, vol.410, issue.1, pp.1-13, 2016.
DOI : 10.1016/j.ydbio.2015.12.013

J. Chen, E. Mandel, J. Thomson, Q. Wu, T. Callis et al., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nature Genetics, vol.132, issue.2, pp.228-261, 2006.
DOI : 10.1242/dev.01596

J. Chen, Y. Tao, J. Li, Z. Deng, Z. Yan et al., microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7, The Journal of Cell Biology, vol.290, issue.5, pp.867-79, 2010.
DOI : 10.1016/j.cell.2007.03.030

D. Gardner-medwin and J. Walton, The clinical examination of the voluntary muscles, Disorders of voluntary muscles, pp.517-60, 1974.

K. Mamchaoui, C. Trollet, A. Bigot, E. Negroni, S. Chaouch et al., Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders, Skeletal Muscle, vol.1, issue.1, p.34, 2011.
DOI : 10.1089/hum.2008.163
URL : https://hal.archives-ouvertes.fr/inserm-00651121

I. Eisenberg, A. Eran, I. Nishino, M. Moggio, C. Lamperti et al., Distinctive patterns of microRNA expression in primary muscular disorders, Proceedings of the National Academy of Sciences, vol.11, issue.3, pp.17016-17037, 2007.
DOI : 10.1261/rna.7240905

I. Zaharieva, M. Calissano, M. Scoto, M. Preston, S. Cirak et al., Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy, PLoS ONE, vol.3, issue.11, p.80263, 2013.
DOI : 10.1371/journal.pone.0080263.s002

T. Roberts, K. Blomberg, G. Mcclorey, S. Andaloussi, C. Godfrey et al., Expression Analysis in Multiple Muscle Groups and Serum Reveals Complexity in the MicroRNA Transcriptome of the mdx Mouse with Implications for Therapy, Molecular Therapy - Nucleic Acids, vol.1, 2012.
DOI : 10.1038/mtna.2012.26

S. Reilly, X. Liu, R. Carnicer, A. Recalde, A. Muszkiewicz et al., Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase, Science Translational Medicine, vol.12, issue.340, pp.340-74, 2016.
DOI : 10.1152/ajpheart.00411.2009

S. Deng, Q. Zhao, X. Zhou, L. Zhang, L. Bao et al., Neonatal heartenriched miR-708 promotes differentiation of cardiac progenitor cells in rats, Int J Mol Sci, vol.17, 2016.

H. Shen, T. Liu, L. Fu, S. Zhao, B. Fan et al., Identification of microRNAs involved in dexamethasone-induced muscle atrophy, Molecular and Cellular Biochemistry, vol.182, issue.5, pp.105-118, 2013.
DOI : 10.1083/jcb.200712110

Y. Wang, D. Newton, G. Robb, C. Kau, T. Miller et al., RNA diversity has profound effects on the translation of neuronal nitric oxide synthase, Proceedings of the National Academy of Sciences, vol.9, issue.2, pp.12150-12155, 1999.
DOI : 10.1038/ng0295-184

L. Hou, J. Xu, H. Li, J. Ou, Y. Jiao et al., MiR-34c represses muscle development by forming a regulatory loop with Notch1, Scientific Reports, vol.25, issue.1, p.9346, 2017.
DOI : 10.1016/j.jnutbio.2014.07.007

A. Molza, K. Mangat, L. Rumeur, E. Hubert, J. Menhart et al., Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17, Journal of Biological Chemistry, vol.265, issue.49, pp.29531-29572, 2015.
DOI : 10.1038/nm0302-253
URL : https://hal.archives-ouvertes.fr/hal-01214011

J. Brenman, H. Xia, D. Chao, S. Black, and D. Bredt, Regulation of Neuronal Nitric Oxide Synthase through Alternative Transcripts, Developmental Neuroscience, vol.19, issue.3, pp.224-255, 1997.
DOI : 10.1159/000111211

O. Baum, S. Schläppi, F. Huber-abel, A. Weichert, H. Hoppeler et al., The beta-isoform of neuronal nitric oxide synthase (nNOS) lacking the PDZ domain is localized at the sarcolemma, FEBS Letters, vol.482, issue.20, pp.3219-3242, 2011.
DOI : 10.1016/S0014-5793(00)02038-X

K. Aquilano, S. Baldelli, and M. Ciriolo, Nuclear Recruitment of Neuronal Nitric-oxide Synthase by ??-Syntrophin Is Crucial for the Induction of Mitochondrial Biogenesis, Journal of Biological Chemistry, vol.2013, issue.1, pp.365-78, 2014.
DOI : 10.1002/stem.783

C. Colussi, C. Mozzetta, A. Gurtner, B. Illi, J. Rosati et al., HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment, Proceedings of the National Academy of Sciences, vol.192, issue.2, pp.19183-19190, 2008.
DOI : 10.1016/0003-2697(91)90534-Z

C. Gentil, L. Guiner, C. Falcone, S. Hogrel, J. Peccate et al., Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy, Human Gene Therapy, vol.27, issue.9, pp.712-738, 2016.
DOI : 10.1089/hum.2016.041